β-Carboline-3-carboxamide Antimalarials: Structure-Activity Relationship, ADME-Tox Studies, and Resistance Profiling.

Area of Science:

• Medicinal Chemistry
• Parasitology
• Drug Discovery

Background:

• Artemisinin combination therapy effectiveness is threatened by parasite resistance.
• Novel antimalarial drugs with new mechanisms of action are urgently needed.
• Previous research identified β-carboline 1a as orally efficacious against malaria with low cross-resistance.

Purpose of the Study:

• To synthesize and evaluate new β-carboline derivatives for antimalarial activity.
• To identify potent antimalarial compounds with novel mechanisms of action.
• To assess drug-like properties and cross-resistance profiles of promising derivatives.

Main Methods:

• Synthesis of 91 new β-carboline derivatives.
• In vitro antimalarial evaluation against Plasmodium falciparum strains.
• Assessment of drug-like properties and in vitro barcoded cross-resistance profiling.

Main Results:

• Asexual blood stage growth inhibition data revealed a preference for specific halogenated phenyl rings at the C1-position.
• Compound 42a, a 3,4,5-trichlorophenyl-substituted derivative, was the most potent, showing twice the efficacy of compound 1a.
• Four potent analogues (1a, 1m, 42a, 42m) exhibited no cross-resistance against multiple drug-resistant mutations.

Conclusions:

• The synthesized β-carboline derivatives show significant antimalarial potential.
• Compound 42a and its analogues represent promising leads for new antimalarial drug development.
• The observed lack of cross-resistance suggests a novel mechanism of action for this compound class.